BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 17570934)

  • 1. Alport syndrome and thin basement membrane nephropathy.
    Thorner PS
    Nephron Clin Pract; 2007; 106(2):c82-8. PubMed ID: 17570934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagen type IV nephropathy: genetic heterogeneity examinations in affected Hungarian families.
    Endreffy E; Ondrik Z; Iványi B; Maróti Z; Bereczki C; Haszon I; Györke Z; Worum E; Németh K; Rikker C; Ökrös Z; Túri S
    Mol Cell Probes; 2011 Feb; 25(1):28-34. PubMed ID: 20951199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thin basement membrane nephropathy.
    Savige J; Rana K; Tonna S; Buzza M; Dagher H; Wang YY
    Kidney Int; 2003 Oct; 64(4):1169-78. PubMed ID: 12969134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The renal lesions of Alport syndrome.
    Heidet L; Gubler MC
    J Am Soc Nephrol; 2009 Jun; 20(6):1210-5. PubMed ID: 19470679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic renal failure and shortened lifespan in COL4A3+/- mice: an animal model for thin basement membrane nephropathy.
    Beirowski B; Weber M; Gross O
    J Am Soc Nephrol; 2006 Jul; 17(7):1986-94. PubMed ID: 16775036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and genetic features of the Alport 'syndromes'].
    Pescucci C; Longo I; Mari F; Scala E; Bruttini M; Caselli R; Renieri A
    G Ital Nefrol; 2005; 22(5):466-76. PubMed ID: 16267804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal recessive Alport syndrome: an in-depth clinical and molecular analysis of five families.
    Longo I; Scala E; Mari F; Caselli R; Pescucci C; Mencarelli MA; Speciale C; Giani M; Bresin E; Caringella DA; Borochowitz ZU; Siriwardena K; Winship I; Renieri A; Meloni I
    Nephrol Dial Transplant; 2006 Mar; 21(3):665-71. PubMed ID: 16338941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Collagen IV (alpha3-alpha4) nephropathy].
    Torra R; Tazón B; Ars E; Ballarín J
    Nefrologia; 2005; 25 Suppl 2():29-32. PubMed ID: 16050399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and molecular diagnosis of Alport syndrome.
    Kashtan CE
    Proc Assoc Am Physicians; 1995 Oct; 107(3):306-13. PubMed ID: 8608415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of type IV collagen subchains in the glomerular basement membrane of patients with Alport syndrome with confocal microscopy.
    Su J; Liu ZH; Zeng CH; Wei-Gong ; Chen HP; Li LS
    Nephrol Dial Transplant; 2006 Jul; 21(7):1838-47. PubMed ID: 16574687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial hematuria: A review.
    Plevová P; Gut J; Janda J
    Medicina (Kaunas); 2017; 53(1):1-10. PubMed ID: 28236514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome.
    Marcocci E; Uliana V; Bruttini M; Artuso R; Silengo MC; Zerial M; Bergesio F; Amoroso A; Savoldi S; Pennesi M; Giachino D; Rombolà G; Fogazzi GB; Rosatelli C; Martinhago CD; Carmellini M; Mancini R; Di Costanzo G; Longo I; Renieri A; Mari F
    Nephrol Dial Transplant; 2009 May; 24(5):1464-71. PubMed ID: 19129241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome].
    Endreffy E; Ondrik Z; Kemény E; Vas Z; Maróti Z; Lencse G; Bereczki C; Haszon I; Túri S; Iványi B
    Orv Hetil; 2005 Dec; 146(52):2647-53. PubMed ID: 16468607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thin glomerular basement membrane disease].
    Frascà GM; Balestra E; Fanciulli E; Freddi P; Mazzucchelli R; Montironi R; D'Arezzo M; Sagripanti S
    G Ital Nefrol; 2008; 25(1):49-56. PubMed ID: 18264918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome.
    Nagel M; Nagorka S; Gross O
    Hum Mutat; 2005 Jul; 26(1):60. PubMed ID: 15954103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical spectrum of type IV collagen mutations.
    Lemmink HH; Schröder CH; Monnens LA; Smeets HJ
    Hum Mutat; 1997; 9(6):477-99. PubMed ID: 9195222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COL4A3/COL4A4 mutations link familial hematuria and focal segmental glomerulosclerosis. glomerular epithelium destruction via basement membrane thinning?
    Voskarides K; Pierides A; Deltas C
    Connect Tissue Res; 2008; 49(3):283-8. PubMed ID: 18661361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three novel COL4A4 mutations resulting in stop codons and their clinical effects in autosomal recessive Alport syndrome.
    Dagher H; Yan Wang Y; Fassett R; Savige J
    Hum Mutat; 2002 Oct; 20(4):321-2. PubMed ID: 12325029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome.
    Buzza M; Wang YY; Dagher H; Babon JJ; Cotton RG; Powell H; Dowling J; Savige J
    Kidney Int; 2001 Aug; 60(2):480-3. PubMed ID: 11473630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.